Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
5Y CAGR+160.2%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+160.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
119.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$56.15M+800.8%
2024$6.23M-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$471000.00+320.5%
2019$112000.00+16.7%
2018$96000.00+24.7%
2017$77000.00+49259.0%
2016$156.00-